Parkinson's and Flu Vaccines; Sleep and Life Expectancy; Positive Duchenne Data: A Comprehensive Review
Neurology > General Neurology
--- News and commentary from the world of neurology and neuroscience
December 9, 2025 • 2 min read
In a recent study, researchers found that midlife influenza vaccination did not increase the risk of Parkinson's disease, contrary to initial concerns. This large observational analysis highlights the need for further research into the potential long-term benefits of flu vaccines. Meanwhile, a study on aging mice revealed that voluntary exercise over 30 days enhanced striatal dopamine release and improved motor performance, offering valuable insights into therapeutic strategies for Parkinson's disease.
The correlation between sleep and life expectancy was explored in an analysis of CDC data, which revealed a negative correlation in most U.S. states. This finding underscores the importance of adequate sleep for overall health and longevity. Additionally, a small clinical trial demonstrated that gamma transcranial alternating current stimulation delivered to Alzheimer's patients at home led to improved short-term clinical outcomes.
Capricor Therapeutics announced positive results from a pivotal phase III trial of investigational deramiocel, showing improvements in skeletal and cardiac function in patients with Duchenne muscular dystrophy. Dyne Therapeutics' investigational zeleciment rostudirsen also showed positive outcomes for Duchenne patients with specific gene mutations in a phase I/II trial. Spinogenix reported cognitive improvements in a phase IIa trial of mild-to-moderate Alzheimer's patients treated with investigational tazbentetol.
A Swedish population-based study found a link between impaired kidney function and elevated levels of Alzheimer's blood biomarkers. The annual out-of-pocket healthcare costs for multiple sclerosis patients increased significantly from $1,783 in 2002 to $4,016 in 2021, according to MarketScan data.
Researchers discussed animal studies suggesting that boosting fluid clearance could be a potential strategy to combat Alzheimer's, Huntington's, Parkinson's, and other neurological disorders. Furthermore, a study explored the association between microplastics and Alzheimer's or Parkinson's disease, shedding light on potential environmental factors affecting neurological health.
These findings emphasize the ongoing research and diverse approaches in neurology and neuroscience, offering hope for improved treatments and a deeper understanding of these complex conditions.
